These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 9609267)

  • 41. Oral administration of 17beta-estradiol over 3 months without progestin co-administration does not improve coronary flow reserve in post-menopausal women: a randomized placebo-controlled cross-over CMR study.
    Schwitter J; Kozerke S; Bremerich J; Baltes C; Attenhofer Jost C; Birkhäuser M; Boesiger P; Buser P
    J Cardiovasc Magn Reson; 2007; 9(4):665-72. PubMed ID: 17578722
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Differing effects of low-dose estrogen-progestin therapy and pravastatin in postmenopausal hypercholesterolemic women.
    Davis SR; Goldstat R; Newman A; Berry K; Burger HG; Meredith I; Koch K
    Climacteric; 2002 Dec; 5(4):341-50. PubMed ID: 12626213
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fibrinolytic potential is significantly increased by oestrogen treatment in postmenopausal women with mild dyslipidaemia.
    Gebara OC; Mittleman MA; Walsh BW; Lipinska I; Welty FK; Bellotti G; Muller JE; Sacks FK; Tofler GH
    Heart; 1998 Sep; 80(3):235-9. PubMed ID: 9875081
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Acute and chronic effects of oestradiol on left ventricular diastolic function in hypertensive postmenopausal women with left ventricular diastolic dysfunction.
    Alecrin IN; Aldrighi JM; Caldas MA; Gebara OC; Lopes NH; Ramires JA
    Heart; 2004 Jul; 90(7):777-81. PubMed ID: 15201248
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of Aerodiol administration on cerebral blood flow volume in postmenopausal women.
    Acar M; Cevrioglu AS; Haktanir A; Demirel R; Albayrak R; Degirmenci B; Yucel A; Akyol AM
    Maturitas; 2005 Oct; 52(2):127-33. PubMed ID: 16186075
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ultrasonographic blood flow measurement in the carotid arteries in postmenopausal women.
    Darj E; Bakos O; Naessen T; Persson I
    Gynecol Obstet Invest; 1999; 47(1):20-5. PubMed ID: 9852387
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of hormone replacement therapy on plasma viscosity and Doppler variations in postmenopausal non-smokers and heavy smokers.
    Mancini F; Persico N; Genazzani AD; Volpe A; Battaglia C; De Aloysio D
    Gynecol Endocrinol; 2005 Apr; 20(4):221-6. PubMed ID: 16019365
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of estrogen and estrogen-progestogen therapy on homocysteine levels and their correlation with carotid vascular resistance.
    Bonassi Machado R; Chada Baracat E; Eduardo Fernandes C; Marcelo Lakryc E; Rodrigues De Lima G
    Gynecol Endocrinol; 2007 Nov; 23(11):619-24. PubMed ID: 17907004
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Oral ultra-low dose continuous combined hormone replacement therapy with 0.5 mg 17β-oestradiol and 2.5 mg dydrogesterone for the treatment of vasomotor symptoms: results from a double-blind, controlled study.
    Stevenson JC; Durand G; Kahler E; Pertyński T
    Maturitas; 2010 Nov; 67(3):227-32. PubMed ID: 20688442
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Methods and baseline cardiovascular data from the Early versus Late Intervention Trial with Estradiol testing the menopausal hormone timing hypothesis.
    Hodis HN; Mack WJ; Shoupe D; Azen SP; Stanczyk FZ; Hwang-Levine J; Budoff MJ; Henderson VW
    Menopause; 2015 Apr; 22(4):391-401. PubMed ID: 25380275
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Postmenopausal oral estrogen therapy and blood pressure in normotensive and hypertensive subjects: the Estrogen in the Prevention of Atherosclerosis Trial.
    Steiner AZ; Hodis HN; Lobo RA; Shoupe D; Xiang M; Mack WJ
    Menopause; 2005; 12(6):728-33. PubMed ID: 16278616
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Continuous transdermal oestrogen and interrupted progestogen as a novel bleed-free regimen of hormone replacement therapy for postmenopausal women.
    Cameron ST; Critchley HO; Glasier AF; Williams AR; Baird DT
    Br J Obstet Gynaecol; 1997 Oct; 104(10):1184-90. PubMed ID: 9332998
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Delayed hyperemia causing intracranial hypertension after cardiopulmonary resuscitation.
    Iida K; Satoh H; Arita K; Nakahara T; Kurisu K; Ohtani M
    Crit Care Med; 1997 Jun; 25(6):971-6. PubMed ID: 9201049
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Vascular resistance of central retinal artery is reduced in postmenopausal women after use of estrogen.
    Faria AF; de Souza MA; Geber S
    Menopause; 2011 Aug; 18(8):869-72. PubMed ID: 21471823
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect on endometrium of long term treatment with continuous combined oestrogen-progestogen replacement therapy: follow up study.
    Wells M; Sturdee DW; Barlow DH; Ulrich LG; O'Brien K; Campbell MJ; Vessey MP; Bragg AJ
    BMJ; 2002 Aug; 325(7358):239. PubMed ID: 12153918
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of transdermal and oral oestrogen replacement therapy on C-reactive protein levels in postmenopausal women: a randomised, placebo-controlled trial.
    Post MS; van der Mooren MJ; Stehouwer CD; van Baal WM; Mijatovic V; Schalkwijk CG; Kenemans P
    Thromb Haemost; 2002 Oct; 88(4):605-10. PubMed ID: 12362231
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Diurnal variation in uterine artery blood flow in post-menopausal women on oestrogen hormone replacement therapy.
    Jurkovic D; Ross D; Aslam N; Whitehead M
    Hum Reprod; 1999 Nov; 14(11):2716-9. PubMed ID: 10548607
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Oestrogen versus androgen in hormone-replacement therapy for complete androgen insensitivity syndrome: a multicentre, randomised, double-dummy, double-blind crossover trial.
    Birnbaum W; Marshall L; Werner R; Kulle A; Holterhus PM; Rall K; Köhler B; Richter-Unruh A; Hartmann MF; Wudy SA; Auer MK; Lux A; Kropf S; Hiort O
    Lancet Diabetes Endocrinol; 2018 Oct; 6(10):771-780. PubMed ID: 30075954
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The metabolic and bone density effects of continuous combined 17-beta estradiol and noresthisterone acetate treatments in Thai postmenopausal women: a double-blind placebo-controlled trial.
    Bunyavejchevin S; Limpaphayom KK
    J Med Assoc Thai; 2001 Jan; 84(1):45-53. PubMed ID: 11281499
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effect of continuous combined hormone replacement therapy on arterial reactivity in postmenopausal women with established angina pectoris.
    Haines CJ; Yim SF; Sanderson JE
    Atherosclerosis; 2001 Dec; 159(2):467-70. PubMed ID: 11730828
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.